Market Overview The exocrine pancreatic insufficiency treatment market is expanding as improved diagnostics identify previously unrecognized cases among patients with diabetes, celiac disease, inflammatory bowel disease, and post-surgical malabsorption. This underdiagnosed condition often masquerades as irritable bowel syndrome or unexplained weight loss, delaying appropriate enzyme...